| Patents for G01N 33 - Investigating or analysing materials by specific methods not covered by groups (393,632) |
|---|
| 12/13/2001 | WO2001094936A1 Novel method of testing myelotoxicity with the use of flow cytometer |
| 12/13/2001 | WO2001094935A2 Labeling of proteomic samples during proteolysis for quantitation and sample multiplexing |
| 12/13/2001 | WO2001094921A2 A pH SENSOR SYSTEM AND METHOD FOR USING SAME |
| 12/13/2001 | WO2001094920A2 3d array of integrated cells for the sampling and detection of air bound chemical and biological species |
| 12/13/2001 | WO2001094916A1 Non-dispersive ir measurement of gases using an optical filter |
| 12/13/2001 | WO2001094641A2 Gene targets and ligands that bind thereto for treatment and diagnosis of ovarian carcinomas |
| 12/13/2001 | WO2001094638A2 Asynchronous primed pcr |
| 12/13/2001 | WO2001094636A2 Compositions, kits, and methods for identification and modulation of type i diabetes |
| 12/13/2001 | WO2001094635A2 Integrated active flux microfluidic devices and methods |
| 12/13/2001 | WO2001094634A2 Methods and devices for multiplexing amplification reactions |
| 12/13/2001 | WO2001094631A1 Methods for detection of cryptosporidium species and isolates and for diagnosis of cryptosporidiuminfections |
| 12/13/2001 | WO2001094630A2 Compositions and methods for array-based nucleic acid hybridization |
| 12/13/2001 | WO2001094629A2 Cancer gene determination and therapeutic screening using signature gene sets |
| 12/13/2001 | WO2001094627A2 Assay techniques based on growth stage dependent expression in c. elegans |
| 12/13/2001 | WO2001094623A1 Assay for detection of translocase enzyme activity in drug screening |
| 12/13/2001 | WO2001094622A1 Assay for detection of transferase enzyme activity in drug screening |
| 12/13/2001 | WO2001094621A1 Screening method for modulators of suv39h2-methyltransferase |
| 12/13/2001 | WO2001094620A1 Screening-method for modulators of methyltransferase-dependent chromosome stability |
| 12/13/2001 | WO2001094619A1 Method of analyzing components in biological samples |
| 12/13/2001 | WO2001094618A1 Method of detecting saccharified albumin |
| 12/13/2001 | WO2001094617A2 Protein fragment complementation assay based on beta-lactamase |
| 12/13/2001 | WO2001094613A2 Methods and compounds for influencing beta3 integrin-dependent intracellular processes |
| 12/13/2001 | WO2001094609A1 Charge-switch nucleotides |
| 12/13/2001 | WO2001094587A2 Extracellular messengers |
| 12/13/2001 | WO2001094582A1 Novel g protein-coupled receptor protein and dna thereof |
| 12/13/2001 | WO2001094580A1 Novel g-protein coupled receptor |
| 12/13/2001 | WO2001094550A2 Identification and use of molecular markers indicating cellular reprogramming |
| 12/13/2001 | WO2001094549A2 Methods of differentiating and protecting cells by modulating the p38/mef2 pathway |
| 12/13/2001 | WO2001094528A2 Visual-servoing optical microscopy |
| 12/13/2001 | WO2001094527A2 Preparing a sample to be analysed from a sample with very large volume |
| 12/13/2001 | WO2001094415A2 Nuclear hormone receptor |
| 12/13/2001 | WO2001094413A2 B7-related nucleic acids and polypeptides and their uses for immunomodulation |
| 12/13/2001 | WO2001094410A1 Insulin regulated substance (irs-2) induced by pioglitazone, assay and use thereof |
| 12/13/2001 | WO2001094391A2 Intracellular signaling proteins |
| 12/13/2001 | WO2001094380A2 Isolated human transporter proteins, nucleic acid molecules encoding human transporter proteins, and uses thereof |
| 12/13/2001 | WO2001094377A2 Metalloprotease peptide substrates and methods |
| 12/13/2001 | WO2001094375A1 Large conductance calcium-dependent potassium channel as modulator of alcohol effects and consumption |
| 12/13/2001 | WO2001094328A1 Stable isotope labeling of paclitaxel |
| 12/13/2001 | WO2001094032A1 Method for producing surface-functionalized supports used as starting products for microarrays, for immobilizing biomolecules |
| 12/13/2001 | WO2001094003A2 Method and apparatus for washing and drying pins in microarray spotting instruments |
| 12/13/2001 | WO2001093989A2 Methods and apparatus for separating and detecting specific polyhalogenated diaromatic hydrocarbons |
| 12/13/2001 | WO2001093983A1 Secreted and transmembrane polypeptides and nucleic acids encoding the same |
| 12/13/2001 | WO2001093944A1 Hematocrit sampling system |
| 12/13/2001 | WO2001093916A1 Purification of functionalized fluorescent nanocrystals |
| 12/13/2001 | WO2001093892A1 Methods and compositions for inhibiting immunoglobulin-mediated__reperfusion injury |
| 12/13/2001 | WO2001093743A2 Breath ketone analyzer |
| 12/13/2001 | WO2001093669A2 Compound screens relating to insulin deficiency or insulin resistance |
| 12/13/2001 | WO2001072772A3 Calcium binding regulatory subunit |
| 12/13/2001 | WO2001055719A3 Diagnostic kit for detecting creatine levels |
| 12/13/2001 | WO2001047470A3 Test tray, kit and methods for bodily fluid testing for newborn screening by tandem mass spectrometry |
| 12/13/2001 | WO2001044445A3 Human lyases and associated proteins |
| 12/13/2001 | WO2001044439A3 Glucocorticoid induced receptor (hgir,rp-23) ligand screening |
| 12/13/2001 | WO2001044269A3 Brain protein markers |
| 12/13/2001 | WO2001042787A3 Immunoassay for neonicotinyl insecticides |
| 12/13/2001 | WO2001042784A3 Methods for screening compounds active on neurons |
| 12/13/2001 | WO2001042495A3 Products comprising a support whereon are fixed nucleic acids and their use as dna chip |
| 12/13/2001 | WO2001041701A3 The combination of a serotonin reuptake inhibitor and a 5-ht2c antagonist, inverse agonist or partial agonist |
| 12/13/2001 | WO2001040502A3 Thin layer chromatographic detection of antibiotics |
| 12/13/2001 | WO2001040475A3 Heme proteins hemat-hs and hemat-bs and their use in medicine and microsensors |
| 12/13/2001 | WO2001040435A3 Method for measuring changes in the gas composition during reaction processes |
| 12/13/2001 | WO2001040269A3 Compositions and methods for therapy and diagnosis of breast cancer |
| 12/13/2001 | WO2001038850A3 Intrinsic dissolution apparatus with stationary sample holder |
| 12/13/2001 | WO2001036681A3 Immunological detection of rna:dna hybrids on microarrays |
| 12/13/2001 | WO2001035087A3 A gas sensor seal and method of producing same |
| 12/13/2001 | WO2001033213A3 Carbon monoxide emitting apparatus, carbon monoxide monitor shutoff, and circuit therefor |
| 12/13/2001 | WO2001032184A3 Abc1 modulation for the modulation of cholesterol transport |
| 12/13/2001 | WO2001030987A3 Tankyrase h, compositions involved in the cell cycle and methods of use |
| 12/13/2001 | WO2001025487A3 Electrochemiluminescence helicase assay |
| 12/13/2001 | WO2001023885A8 Test device |
| 12/13/2001 | WO2001020026A3 POLYMORPHISMS IN THE HUMAN hPXR GENE AND THEIR USE IN DIAGNOSTIC AND THERAPEUTIC APPLICATIONS |
| 12/13/2001 | WO2001011038A3 Medicament for the prevention and/or the treatment of ischemic heart and peripheral vascular diseases, tumour and wounds |
| 12/13/2001 | WO2000058514A3 Methods for improving sensitivity and specificity of screening assays |
| 12/13/2001 | WO2000044888A3 Dimethylarginine dimethylaminohydrolases |
| 12/13/2001 | WO2000032773A9 Compositions and methods for increasing bone mineralization |
| 12/13/2001 | WO2000029008A9 Hiv-specific t-cell induction |
| 12/13/2001 | WO2000015845A9 T-type calcium channel |
| 12/13/2001 | WO2000014115A9 Mc4-r as target for the identification of compounds used to treat drug addiction |
| 12/13/2001 | WO2000008043A9 Prevention and treatment of viral disease |
| 12/13/2001 | WO1999061888A3 Microfabricated cell sorter |
| 12/13/2001 | US20010051855 Computationally targeted evolutionary design |
| 12/13/2001 | US20010051844 Process control method for vented polymerizers |
| 12/13/2001 | US20010051717 Beta (1-3) -glucan diagnostic assays |
| 12/13/2001 | US20010051379 Method for detecting drugs, and a solvent and a decomposition solution used therefor |
| 12/13/2001 | US20010051378 Method for the analysis of gaseous components and test kit, in particular test kit for the implementation of this method |
| 12/13/2001 | US20010051372 Monoclonal immunoglublin; for use in gene therapy and cell transplantation |
| 12/13/2001 | US20010051366 Transferring particles through cell barriers; insert cell into electrically conductive fluid, monitor electrical current, adjust voltage to maintain preferential diffusion |
| 12/13/2001 | US20010051361 Isolated human transporter proteins, nucleic acid molecules encoding human transporter proteins, and uses thereof |
| 12/13/2001 | US20010051353 Method for using multicellular particulates to analyze malignant or hyperproliferative tissue |
| 12/13/2001 | US20010051352 Multilayer test strip |
| 12/13/2001 | US20010051351 Antigen-specific immune complex-based enzyme-linked immunosorbent assay |
| 12/13/2001 | US20010051350 Diagnostic detection device and method |
| 12/13/2001 | US20010051349 Immobilization |
| 12/13/2001 | US20010051348 Complexing |
| 12/13/2001 | US20010051347 Specific antibodies to kringle 5 of apo(a) and methods of use therefor |
| 12/13/2001 | US20010051346 Assay |
| 12/13/2001 | US20010051345 Method for detecting deficient cellular membrane tightly bound magnesium for disease diagnoses |
| 12/13/2001 | US20010051337 Analyzing miniature deposits |
| 12/13/2001 | US20010051333 Detecting amino acid sequences in viral polypeptide; evaluate and compare patterns of chemical shifts in preferential polypeptides |
| 12/13/2001 | US20010051332 Detecting preferential viral protein; mix sample and antibody, detect and measure binding of antibody, compare to control |
| 12/13/2001 | US20010051331 Fluorescence polarization method |